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Abstract: DNA nanopores offer a unique nano-scale foothold at the membrane interface that can help
advance the life sciences as biophysical research tools or gate-keepers for drug delivery. Biological
applications require sufficient physiological stability and membrane activity for viable biological
action. In this report, we determine essential parameters for efficient nanopore folding and membrane
binding in biocompatible cell media. The parameters are identified for an archetypal DNA nanopore
composed of six interwoven strands carrying cholesterol lipid anchors. Using gel electrophoresis and
fluorescence spectroscopy, the nanostructures are found to assemble efficiently in cell media, such as
LB and DMEM, and remain structurally stable at physiological temperatures. Furthermore, the pores’
oligomerization state is monitored using fluorescence spectroscopy and confocal microscopy.
The pores remain predominately water-soluble over 24 h in all buffer systems, and were able to bind
to lipid vesicles after 24 h to confirm membrane activity. However, the addition of fetal bovine serum
to DMEM causes a significant reduction in nanopore activity. Serum proteins complex rapidly to the
pore, most likely via ionic interactions, to reduce the effective nanopore concentration in solution.
Our findings outline crucial conditions for maintaining lipidated DNA nanodevices, structurally and
functionally intact in cell media, and pave the way for biological studies in the future.
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1. Introduction
DNA nanotechnology excels at the bottom-up fabrication of engineered nanostructures. DNA
duplexes can be manipulated into user-defined shapes by exploiting the base-pairing rules for
duplex formation [1–3]. Discrete nanostructures can be assembled in two and three dimensions with
sub-nanometer control using dedicated design software [4,5]. Chemical diversity and functionality can
be incorporated into structures site-specifically using, for example, solid phase DNA synthesis [6,7],
or non-specifically via intercalation [8,9], or electrostatic interactions [10,11]. This rapidly evolving field
has transformed materials science with wide-ranging applications, including the generation of DNA
origami devices for optical sensing [12], controlled single molecule synthesis using a lab-on-a-chip
DNA board [13], computation devices [14,15], and finite sub-nm movement of DNA-based robots
using DNA ligands [16].
DNA nanotechnology applied to the life sciences is gaining traction. DNA nanostructures
can help control processes within cells, or at the membrane interface to advance biological
understanding [17–20]. This progress includes the generation of novel diagnostic tools [21–23], the
enhancement of existing drugs [24], and devices with novel therapeutic action [25]. Recently,
intracellular DNA-based delivery vehicles have been used to transport biomolecules. Engineered DNA
cages that encapsulate small molecule drugs [25], mRNA [26], peptides, and proteins [27,28] have
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been developed to deliver biomolecular cargo. DNA nanostructures can be internalized in specific
mammalian cells, although the nature of the design appears to play an important role [29,30]. Coating
the nanostructures in certain chemical groups can improve cellular uptake [10,31,32].
To fulfill desirable biomolecular functions, the DNA nanostructures have to be stable. DNA
origami-based nanostructures have been studied previously in vitro and in vivo [33]. Generally,
the origami constructs withstand diverse biology conditions under short time durations. Yan and
colleagues have recently shown intact and functional DNA origami in the renal system of a mouse
model [34]. However, other reports have identified significant degradation and unfolding of DNA
origami structures in biological media [35,36]. This instability has been attributed to the low level of
Mg2+ ions—essential to stabilize DNA origami nanostructures—and digestion from enzymes including
DNAses. The susceptibility to degradation appears to be design-specific, with tubular designs proving
more resilient [37]. Other strategies can be employed to help stabilize the nanostructures, including
chemical ligation of DNA nicks [38], the introduction of non-native base pairs, such as LNA, PNA,
and XNA [39]. Alternatively, cationic peptides [10], polymers [32], or intercalators [9] can be used to
improve structural stability.
DNA-based nanopores are the most recent class of membrane channels which can potentially
offer a unique degree of control at the membrane interface [40–44]. Naturally occurring nanopores are
usually composed of proteins or peptides to help regulate ion transport across cell membranes [45].
However, it can be challenging to de novo design amino acid-based nanopores due to unexpected
protein misfolding [46]. In contrast, utilizing DNA as a construction material can help overcome this
issue. To date, DNA nanotechnology has produced nanopores with highly customizable properties,
including channel diameter, length, functionalized groups within the lumen, and ligand-controlled
pore opening [40–44]. For future biological applications, including pore-mediated drug delivery,
nanopore stability and solubility within biological media must be maintained.
To investigate DNA nanopore stability, this study employs the DNA nanopore NP-3C
(Figure 1a) [42]. The pore is assembled from six single strands (Tables S1 and S2, Figures S1 and
S2), which form six interwoven DNA duplexes to generate a six helical barrel. Three cholesterol
lipid anchors are site-specifically incorporated to the exterior of the bundle to facilitate membrane
binding and nanopore behavior. The assembled pore punctures the membrane to generate a toroidal
pore to enable ion transport across the lipid bilayer (Figure 1b) [44,47,48]. However, the hydrophobic
lipid anchors can also mediate other undesired behavior, including intermolecular oligomerization
(Figure 1c) [49,50]. To help distinguish the lipid anchor effect, a cholesterol-free version, NP-0C,
was assembled to serve as a negative control (Tables S1 and S2, Figure S1).
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Cell media is composed of complex ions and nutrients which help to maintain cell homeostasis and
phenotype. For biological applications, the amphiphilic DNA nanostructures must remain structurally
stable within the used medium. Therefore, this report assayed biologically compatible media to
identify the pore’s structural stability and membrane activity, including phosphate-buffered saline
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(PBS), bacterial growth medium lysogeny broth (LB), mammalian cell media Dulbecco’s modified Eagle
medium (DMEM), and DMEM supplemented with 10% v/v fetal bovine serum (FBS) (Table 1) [51,52].
Serum is required for specific cell types to maintain cell function, and is composed of a wide array
of entities including proteins, hormones, and electrolytes. The total protein concentration in FBS is
~0.3–0.5 mg/mL [53]. Albumin, globulin, and fibrinogen make up the majority of proteins found in
serum, at approximately 55, 38, and 7%, respectively. In addition, over a thousand other regulatory
proteins exist at much smaller levels. Metal ions must also be considered. Positively charged metal ions
coordinate with DNA ionically to stabilize duplexes. Therefore, a range of metal cations was assayed
to identify the counterion stabilization on the nanostructures [33]. We tested monovalent sodium and
potassium ions typically used for single channel current recordings used to study nanopores [54],
and divalent magnesium ions, conventionally used for the stabilization of DNA origami constructs.
The nanopore formation was determined using gel electrophoresis. To identify the thermal stability
at physiological temperatures in biological media, the melting temperatures of the constructs were
identified using fluorescence spectroscopy [55]. Further, our study identified the aggregation extent
of the nanostructures using fluorescence spectroscopy and confocal microscopy over time. Finally,
to confirm membrane activity of the nanopore, binding to model membranes was determined using
fluorescence microscopy. With the knowledge gained using our approach, new pore formulations and
folding protocols can be established which should help provide insights for future applications across
the life sciences.
Table 1. Buffer solutions and biological media including their ionic strength.
Abbreviation Na K Mg PBS LB D FBS








D + 10% fetal
bovine serum
Ionic strength 0.32 M 0.32 M 0.11 M 0.17 M 0.17 M 0.17 M 0.19 M
2. Materials and Methods
All reagents were purchased from Sigma Aldrich (UK) unless stated otherwise. The DNA
nanopore was published previously (information on the sequences, including 2D maps and dimensions
is provided in the Supporting Information) [42]. The DNA nanopores were assembled by mixing an
equimolar mixture of the component DNA strands (0.5 µM, unless stated otherwise) (Integrated DNA
Technologies, Coralville, IA, USA) containing the stated buffer or media. The nanopores were folded
by heating the solution from 95 ◦C for 2 min, and cooling to 20 ◦C at a rate of 5 ◦C per min. The folded
DNA nanopore constructs were stored at room temperature, and vortexed for 2 s before use. Where
stated, n-octyl-oligo-oxyethylene (OPOE) (Enzo Life Sciences, Exeter, UK) was added to the folding
mixture prior to nanopore assembly (1.5% v/v).
Buffer and reagents. Na: NaCl 300 mmol/L, tris 15 mmol/L, pH 8.0. K: KCl 300 mmol/L,
tris 15 mmol/L, pH 8.0. Mg: MgCl2 14 mmol/L, tris 40 mmol/L, acetic acid 20 mmol/L,
ethylenediaminetetraacetic 1 mmol/L, pH 8.3. PBS: NaCl 137 mmol/L, KCl 2.7 mmol/L, Na2HPO4
8 mmol/L, KH2PO4 2 mmol/L, pH 7.4. LB: tryptone 10 mg/mL; yeast extract 5 mg/mL; NaCl 10
mg/mL values taken from [56]. D components include CaCl2 2.4 mmol/L, MgSO4 0.8 mmol/L, KCl 5.4
mmol/L, NaHCO3 44.0 mmol/L, NaCl 109.5 mmol/L, NaH2PO4 0.9 mmol/L. Neat fetal bovine serum
components include bilirubin 2.4 mg/L; Cholesterol 340 mg/L; creatinine 27.3 mg/L; urea 260 mg/L;
Na+ 142 mmol/L; Cl− 155.5 mmol/L; K+ 8 mmol/L; Ca2+ 3 mmol/L; Mg2+ 1.1 mmol/L; PO43−
2.3 mmol/L; Fe 1.6 mg/L; glucose 550 mg/L; protein 36 g/L; albumin 17 g/L; α-globulin 17 g/L;
β-globulin 2 g/L; γ-globulin 1 g/L, values taken from [57].
DNA nanopore folding was characterized using 12% sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) (Bio-Rad, Watford, UK) with standardized buffers typically applied to
proteins. The gel was thermally equilibrated at 8 ◦C prior to loading. The gel was run at 140 V for
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70 min. The bands were visualized by first removing SDS with deionized water, then stained using
ethidium bromide solution. A 100 base-pair DNA marker (New England Biolabs, Hitchin, UK) was
used as a reference.
The Förster resonance energy transfer (FRET) characteristics of the fluorescein (FAM) and Cy3
labeled nanopore constructs were identified using a Varian Eclipse fluorescence spectrophotometer
(Agilent, Stockport, UK). 20 µL of the various DNA nanostructures (folded in PBS at 1 µM) (see Tables
S1 and S2 for strand information) was added to PBS (180 µL) in a quartz cuvette with a path length
of 1 cm. The samples were analyzed by excitation at 495 nm, and the emission monitored between
505–700 nm. A 5 nm slit width and 600 PMT voltage was applied, along with a scanning rate of 600 nm
per min; the scan was performed 3 times and averaged.
The melting transitions of the DNA nanostructures were identified using a MyIQ real-time PCR
(Bio-Rad, Watford, UK). The nanostructures were assembled containing FAM and Cy3 FRET pairs
(folded at 1 µM in PBS). The DNA constructs were diluted into the stated buffer systems to give a
final DNA concentration of 0.1 µM (total volume of 25 µL) in a 96-well thin wall fluorescence plate
(Bio-Rad, Watford, UK). Optical quality sealing tape (Bio-Rad, Watford, UK) was placed on top to
prevent evaporation. The sample was heated from 30–85 ◦C at a rate of 0.5 ◦C per min. The melting
temperature was determined from taking the derivative of the donor fluorescence profile. Errors were
identified from 3 independent experiments.
Fluorescence spectroscopic analysis was performed on Cy3-modified DNA nanostructures using
a Varian Eclipse fluorescence spectrophotometer (Agilent, Stockport, UK) with a fluorescence cuvette.
The samples were analyzed by excitation at 540 nm, and by monitoring the emission from 550–600 nm,
using a 10 nm slit width, 800 PMT voltage, scanning at 600 nm per min and taking the average of 3
repeat scans. The DNA nanostructures (2 µL, folded at 0.5 µM) in the stated buffers were scanned
once the folding temperature reached 40 ◦C by diluting in the buffer systems (200 µL final volume).
At the designated time points, the samples were centrifuged for 10 min at 16k revolutions per min at
room temperature (Eppendorf, Stevenage, UK), and the supernatant was carefully extracted and the
fluorescence monitored using the same dilution and settings as described.
Confocal laser scanning microscopy (CLSM) images were collected using a 60× oil objective
FV-1000 Olympus microscope. Images were analyzed using ImageJ software. To image the DNA
nanopore constructs, the folded pore containing a Cy3 dye (10 µL, 0.5 µM in PBS) was deposited
on a fluorodish (World Precision Instruments, Sarasota, FL, USA), and left to settle for 20 min
prior to imaging. For the vesicle-binding assays, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) giant unilamellar vesicles (GUVs) were prepared by modifying a published protocol [48,58].
POPC (150 µL, 10 mM) in chloroform was added to a 1 mL glass vial, the solvent was removed under
vacuum, and underwent rotation using a rotary evaporator. The thin film generated was resuspended
in mineral oil (150 µL) by vortexing and sonicating for 10 min. Green fluorescent protein (5 µL,10 µM
in PBS) was mixed with sucrose solution (20 µL, 400 mM), followed by addition of mineral oil (150 µL).
The suspension was vortexed and sonicated for 10 min at room temperature, then carefully added to
the top of a glucose solution (1 mL, 400 mM) in a plastic vial (1 mL). The vesicles were generated by
centrifuging at 16K RPM at 4 ◦C for 10 min. The mineral oil top layer and the majority of the sucrose
layer (~800 µL) were carefully removed. The remaining solution containing the pelleted vesicles was
gently mixed with a pipettor, then transferred to a clean plastic vial. The POPC GUVs (5 µL) were
added to a KCl solution (5 µL, 0.5 M), and then Cy3-labeled NP-3C (2 µL folded at 0.25 µM) in the
stated buffers was mixed, and the solution deposited on the confocal slide and used within 24 h.
For the serum time series assay, NP-3C (10 µL, 0.25 µM folded in PBS) was added to FBS (10 µL) for
the stated time durations. The NP-3C-FBS solution (4 µL) was added to the GUV solution as described
above. All images were collected after 20 min using identical settings.
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3. Results
3.1. Determining Nanopore Formation in Media
The folding efficiency of the DNA nanopores in biological media was analyzed using SDS-PAGE
(Figure 2). First, the formation of the folded barrel was confirmed by assembling NP-0C, as well
as versions missing some of the component strands (Figure 2a). Combining all six strands yielded
the slowest migrating band slightly above the 1517 base pair marker band, as indicated by the top
arrow. Removal of a single strand from the folding mixture resulted in an increase in band mobility.
The 5-component construct migrated towards the 500 base pair marker band, as indicated by the bottom
arrow. The large shift in band migration between a fully and partially assembled barrel is consistent
with the formation of a higher order tertiary nanostructure. However, the strand combinations 1–4
and 1–3 also gave rise to a band migrating aligned to the 500 bp marker band. This result indicates
that the addition of strands 4 and 5 to the pooled mixture did not successfully incorporate within
the assembled bundle. Comparing component strands 1–2 and 1 gave the expected step-wise change
indicating successful assembly.
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The assembled NP-0C construct folded efficiently in all biological buffers as assayed by SDS-PAGE
(Figure 2b). This result confirmed stable DNA nanostructure formation in diverse media over short
time durations, even in the presence of low salt conditions. After 24 h the gel was repeated, all bands
showed very similar behavior—except for the media containing FBS—indicating that the pores are
generally stable under these varied conditions. Adding protein-containing FBS led to the formation
of protein-DNA complexes that did not migrate into the gel. The surfactant in the gel buffer, sodium
dodecyl sulfate (SDS), was not able to disrupt the protein binding to the DNA nanostructure.
3.2. Identifying Nanopore Melting Temperatures in Biological Media
The thermal stability of the pores was established using DNA nanostructures labeled with a
fluorophore pair for Förster resonance energy transfer (FRET). FAM (fluorescein) (donor) and Cy3
(acceptor) FRET pairs [59] were incorporated into the nanostructures on strands 2 and 6, respectively
(see the Supporting Information for details for the DNA strands) (Figure 3a). Successful FRET was
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confirmed by scanning the donor emission in the absence and presence of the acceptor in assembled
NP-3C (Figure 3b). Next, the donor emission was monitored upon heating (Figure 3c). The donor
profile gave rise to a sigmoidal curve and its derivative yielded the melting transition. All constructs in
the media types displayed melting transitions significantly above physiological temperatures (Table 2).
Monovalent sodium and potassium gave very similar melting transitions for NP-3C, at 51.3 ◦C and 52.2
◦C, respectively. However, divalent magnesium gave rise to a 1.6 ◦C enhancement, even though the
counterion concentration was significantly lower. Biologically compatible PBS reduced the structural
stability by 4 ◦C, possibly due to the lower concentration of monovalent sodium (137 mM). However,
the overall high thermal stability of all the nanostructures in all the media conditions confirmed their
suitability for biological applications from a structural perspective.
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Table 2. Melting temperatures of DNA nanopore constructs in stated salt and media systems. Errors
were identified from three independent experiments.
Construct Na K Mg PBS LB D FBS
NP-0C 49.7 ± 0.3 50.9 ± 1.2 52.7 ± 0.3 46.4 ± 0.9 46.6 ± 0.3 45.8 ± 0.3 45.7 ± 0.3
NP-3C 51.3 ± 0.6 52.2 ± 0.8 53.8 ± 1.5 46.7 ± 0.3 45.0 ± 1.0 46.8 ± 0.3 47.2 ± 0.3
3.3. Identifying Time-Dependent Nanopore Water-Solubility
We tested the water solubility of constructs in the different media conditions. Centrifugation
was used to pellet and separate any large NP-3C clusters from smaller water-soluble fractions.
The fluorescence in the supernatant was quantified using a fluorometer (Figure 4a), and fluorescence
in the pellet using confocal laser scanning microscopy (CLSM) (Figure 4b). The cholesterol-free
construct remained predominantly water-soluble over the course of 48 h in all assayed media.
The cholesterol labeled nanopore, NP-3C, showed some aggregation and pelleting after 24 h. However,
the majority of the oligomerized and monomeric form remained water soluble (>75%) even after 48 h.
The protein-DNA complexes generated by FBS resulted in a noticeable increase in the pelleting fraction;
however, the majority of complexed NP-3C in FBS remained water-soluble. By comparison, NP-0C
showed no aggregation either in the supernatant, or CLSM images after 48 h across all conditions.
This result confirms the cholesterol lipid anchors were responsible for the detectable pelleting observed.
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3.4. Identifying Nanopore Membrane Binding Activity in Media
We tested the ability of DNA nanopores to bind to vesicles in media. The DNA nanopores
binding towards giant unilamellar vesicles (GUVs) was identified using CLSM (Figure 5). Green
fluorescence protein (GFP) was encapsulated inside the GUVs to aid visualization. Cy3-labeled NP-3C
in PBS, LB, or DMEM was diluted into the GUV solution to minimize the effect different salts and
buffers have on dye fluorescence. Extensive membrane binding to GUVs was observed for these
combinations, as shown by intense membrane halos around the vesicles’ perimeter. In contrast, NP-3C
in serum-containing media blocked the nanopores’ binding event significantly. In agreement with
SDS-PAGE analysis described above, FBS proteins complexed to the pore, via the generation of a higher
molecular weight complex which prevents cholesterol-mediated binding. However, this problem
can be circumvented by minimizing t e pores exposure to FBS prior to vesicl addition. Adding the
pores to FBS for 20 min, or directly from PBS, followed by addition to GUVs resulted in significant
membrane binding, comparable to the other media conditions. This is an important finding for future
lipidated DNA nanodevices employed in serum-containing media.
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Figure 5. Confocal microscopy shows NP-3C bin i g to GUVs in biological buffers while FBS
complexes to NP-3C to block membrane tethering. (a) Cy3-labeled NP-3C (magenta) mixed in the stated
buffers for 1 h, and NP-3C added to FBS for different time periods, then added to GUVs containing GFP
(green), image collected after 20mins of pore-vesicle incubation on a glass slide; (b) relative membrane
fluorescence intensities from (a). All images collected under identical conditions. Error bars represent
the averages of three experiments. Scale bar 10 µm.
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3.5. Adding Detergent Prevents Nanopore Aggregation
We employed the non-ionic surfactant n-octyl-oligo-oxyethylene (OPOE) to generate a DNA
nanopore-detergent complex to improve solubility and prevent aggregation. Naturally occurring
membrane proteins are amphiphilic and can aggregate due to poor aqueous solubility. To help
overcome this issue surfactants are routinely utilized to extract, solubilize, and stabilize membrane
proteins [60]. OPOE was previously shown to aid DNA nanopore insertion into membranes during
single channel current recordings [42]. We tested whether the surfactant can reverse pre-aggregation
of nanopores using the centrifugation assay described above. The surfactant was added in high
concentrations above the critical micelle concentration (CMC). OPOE was added after incubating the
pore 48 h in FBS. CLSM revealed NP-3C aggregates after the addition of OPOE (Figure 6a) suggesting
that the surfactant was not able to disrupt the pre-formed NP-3C aggregate. However, when the
detergent was added to the pooled DNA prior to assembly, no aggregates were observed either by
confocal microscopy, or a decrease in the supernatant fluorescence after 48 h (Figure 6a,b). These results
confirm that the mild surfactant was able to solubilize the pores and prevent higher-order assembly
for long durations. These results indicate that future folding protocols should include detergent
within the folding mixture, prior to, or shortly after nanopore folding to help prevent lipidated DNA
nanostructure aggregation.
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Cy3-labeled NP-3C (magenta) in FBS 48 h after folding, with OPOE added at 48 h (left), or prior
to folding (right), all images collected under identical conditions, scale bar 50 µm; (b) fluorescence
analysis of the supernatant fraction after centrifugation of NP-0C (blue) and NP-3C (magenta) folded
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4. Discussion
DNA-based nanopores are a recent and exciting class of synthetic membrane channel.
This construction approach provides a unique level of biophysical control across lipid bilayers. For
DNA nanopores to provide functionality in the life sciences, for example, as biosensors, drug delivery
vehicles, or cytotoxic-inducing agents, biocompatibility needs to be addressed. Essential parameters
before in vitro and in vivo testing include confirming structural stability and solution-phase solubility
in biologically compatible media. We have employed an archetypical DNA nanopore and tested its
folding capabilities in diverse biological media routinely used to culture mammalian or bacterial
cells. The conditions were deliberately chosen to be stringent as folding was performed in the cell
media. It would also have been possible to fold pores in protein-free buffers and then add them to the
protein-containing media. This differential treatment would have, however, made a fair comparison
across all buffers and media more difficult. Our results suggest that pores folded efficiently and
remained structurally stable in all media assayed. Importantly, the pore constructs displayed melting
temperatures above physiological temperatures, even in the absence of divalent magnesium ions. With
the exception of FBS-containing media, the DNA nanopores remained predominately water soluble
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in all conditions tested over 48 h. These results reinforce the suitability of DNA nanotechnology as a
good building material for use in biological studies.
Serum proteins cause aggregation most likely due to complexation towards the DNA’s negatively
charged phosphate backbone. Albumin serum proteins have been shown to complex to antisense
oligonucleotides, which in some instances enhances the half-life of intravenously injected DNA [61,62].
However, hydrophobic groups can further increase the protein complexation extent [63]. In the case of
amphiphilic DNA nanopores used in this study, the resultant complexes caused significant aggregation,
drastically reducing the amount of membrane tethering action. This result is an important finding in
the field of lipidated DNA nanostructures, and if the use of FBS is unavoidable, the DNA nanopores
should be applied for short time periods of less than 1 h, or the cells transferred temporarily into other
media, such as phosphate buffered saline. Alternatively, vesicle delivery agents may be employed to
shield the nanostructures from aggregation. Other strategies include using DNA masking groups, such
as coating the structures in polyethylene glycol, or carboxylic acids, both are known to improve the
circulation time of biomolecules in the bloodstream. Cationic groups such as lysine and arginine-rich
peptides [32], polyamines [64], and metal cations can be used to block the serum proteins from binding.
In addition, charge-neutral peptide nucleic acids nanopore equivalents [39] can be developed to
prevent serum complexation. We expect lipidated DNA nanodevices and DNA nanopores to provide
a useful foothold cell biology, and should find use as drug delivery gate-keepers, to function as drug
molecules, such as immunosuppressants or immunoactivators, or act as novel tools in diagnostics
and sensing.
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-4991/9/4/490/s1,
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